117 related articles for article (PubMed ID: 25168216)
21. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
22. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.
Nie S; Yin H; Tan Z; Anderson MA; Ruffin MT; Simeone DM; Lubman DM
J Proteome Res; 2014 Dec; 13(12):6058-66. PubMed ID: 25393578
[TBL] [Abstract][Full Text] [Related]
24. Serum tissue factor as a biomarker for renal clear cell carcinoma.
Silva DD; Noronha JAP; Pinheiro da Costa BE; Zandona PCE; Carvalhal GF
Int Braz J Urol; 2018; 44(1):38-44. PubMed ID: 28727370
[TBL] [Abstract][Full Text] [Related]
25. Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.
Kinouchi T; Uemura M; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Matsuzaki K; Nakata W; Yoshida T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
Cancer Sci; 2017 Dec; 108(12):2495-2502. PubMed ID: 28985012
[TBL] [Abstract][Full Text] [Related]
26. Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics.
Saraswat M; Mäkitie A; Agarwal R; Joenväärä S; Renkonen S
Br J Cancer; 2017 Jul; 117(3):376-384. PubMed ID: 28632724
[TBL] [Abstract][Full Text] [Related]
27. Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
Fedorko M; Stanik M; Iliev R; Redova-Lojova M; Machackova T; Svoboda M; Pacik D; Dolezel J; Slaby O
Int J Mol Sci; 2015 Sep; 16(10):23382-9. PubMed ID: 26426010
[TBL] [Abstract][Full Text] [Related]
28. Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.
Zhang Y; Chen X; Hu Y; Du S; Shen L; He Y; Zhang Y; Zhang X; Li H; Yung RC
Respir Res; 2013 Feb; 14(1):18. PubMed ID: 23399022
[TBL] [Abstract][Full Text] [Related]
29. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
30. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
[TBL] [Abstract][Full Text] [Related]
31. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
[TBL] [Abstract][Full Text] [Related]
33. [Proteomic analysis in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses].
Xu G; Xiang CQ; Lu Y; Kang XN; Wang WJ; Liao P; Ding Q; Zhang YF
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):858-60. PubMed ID: 18756995
[TBL] [Abstract][Full Text] [Related]
34. Comparative Analysis of Blood Plasma Proteome in Patients with Renal Cell Carcinoma.
Kaysheva AL; Kopylov AT; Kushlinskii NE; Gershtein ES; Alferov AA; Morozov AA; Kazantseva IA; Pleshakova TO; Archakov AI; Ivanov YD
Bull Exp Biol Med; 2019 May; 167(1):91-96. PubMed ID: 31177467
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
36. Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.
Nizioł J; Bonifay V; Ossoliński K; Ossoliński T; Ossolińska A; Sunner J; Beech I; Arendowski A; Ruman T
Anal Bioanal Chem; 2018 Jun; 410(16):3859-3869. PubMed ID: 29658093
[TBL] [Abstract][Full Text] [Related]
37. Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
Prieto DA; Johann DJ; Wei BR; Ye X; Chan KC; Nissley DV; Simpson RM; Citrin DE; Mackall CL; Linehan WM; Blonder J
Biomark Med; 2014; 8(2):269-86. PubMed ID: 24521024
[TBL] [Abstract][Full Text] [Related]
38. An integrated proteomic and peptidomic assessment of the normal human urinome.
Di Meo A; Batruch I; Yousef AG; Pasic MD; Diamandis EP; Yousef GM
Clin Chem Lab Med; 2017 Feb; 55(2):237-247. PubMed ID: 27394047
[TBL] [Abstract][Full Text] [Related]
39. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.
Hauser S; Zahalka T; Fechner G; Müller SC; Ellinger J
Anticancer Res; 2013 Oct; 33(10):4651-6. PubMed ID: 24123044
[TBL] [Abstract][Full Text] [Related]
40. Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.
Hatakeyama S; Amano M; Tobisawa Y; Yoneyama T; Tsuchiya N; Habuchi T; Nishimura S; Ohyama C
J Urol; 2014 Mar; 191(3):805-13. PubMed ID: 24140550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]